Stainless steel or single use: what’s the future for pharma?
Across the industry, Blackfield Associates is witnessing a wave of change in the on-site infrastructure of pharmaceutical manufacturing: the switch from traditional stainless steel vessels and bioreactors to the nu-school of single-use systems. What has prompted this change? What are the advantages (or disadvantages) of making the move? And, more importantly, what effect does this…